Benzinga’s Top Downgrades (CB, POT, GSK, SPWRA)
October 23, 2009 11:33 AM
The Chubb Corporation (NYSE: CB) slipped 5.15% to $51.04. Today Stifel Nicolaus cut its rating to Hold from earlier Buy rating.
Potash Corp./Saskatchewan (USA) (NYSE: POT) is trading lower by 2.37% at $100.52 after CIBC downgraded POT to Sector Performer from Sector Outperformer.
GlaxoSmithKline plc (ADR) (NYSE: GSK) fell 3% to $40.33 after Jefferies downgraded GSK to Hold from Buy.
The Chubb Corporation (NYSE: CB) slipped 5.15% to $51.04. Today Stifel Nicolaus cut its rating to Hold from earlier Buy rating.
Potash Corp./Saskatchewan (USA) (NYSE: POT) is trading lower by 2.37% at $100.52 after CIBC downgraded POT to Sector Performer from Sector Outperformer.
GlaxoSmithKline plc (ADR) (NYSE: GSK) fell 3% to $40.33 after Jefferies downgraded GSK to Hold from Buy.
SunPower Corporation (NASDAQ: SPWRA) plunged 14% to $28.65 after The SunPower reduced its full-year earnings forecast after third- quarter profit slumped 48 percent on lower demand for its renewable energy products. Today, RBC Capital reduced its rating from Outperformer to Sector Performer and set a price target of $31.
